Spinal muscular atrophy (SMA) is a severe neurodegenerative autosomal reces
sive disorder, second only in frequency to cystic fibrosis. In its most sev
ere form, SMA type I (Werdnig-Hoffman), death invariably ensues before age
2 years from respiratory failure or infection. Around 98% of clinical cases
of SMA are caused by the homozygous absence of a region of exons 7 and 8 o
f the telomeric copy of the SMN gene (SMN1) on chromosome 5. We have develo
ped a novel means of preimplantation diagnosis of SMA using a nested polyme
rase chain reaction (PCR) amplification of exon 7 of SMN, followed by a Hin
fI restriction digest of the PCR product enabling the important SMN1 gene t
o be distinguished from the centromeric SMN2 gene which has no clinical phe
notype. This method was designed to reduce the likelihood of misdiagnosis.
Five couples were treated using this method. Four proceeded to embryo trans
fer which resulted in six liveborns (one singleton, one twin and one triple
t), all free of SMA. Embryo transfer was not performed in one cycle because
of PCR contamination.